Background and aim of the study: There are many possible determinants of left ventricular (LV) mass, including the angiotensin-converting enzyme (ACE) genotype, which have rarely been compared in aortic stenosis (AS). The study aim was to investigate these determinants in patients with all grades of AS.
Methods: Transthoracic echocardiography and an analysis of ACE genotype was performed in 91 patients with aortic valve thickening and a peak aortic velocity >2.0 m/s.
Results: Univariate relationships were identified between LV mass index and effective orifice area (R = 0.22), and peak transaortic pressure difference (R = 0.36). LV mass index was similar for the ACE-II (152+/-37 g/m2), ACE-ID (145+/-46 g/m2) and ACE-DD (161+/-56 g/m2) genotypes. LV mass index was significantly greater in males (162+/-52 gm/m2) than in females (137+/-38 gm/m2; p = 0.014). The multivariate determinants varied according to the grade of AS: diastolic blood pressure (p = 0.028) in mild stenosis; peak transaortic pressure difference (p = 0.03) in moderate stenosis; and peak transaortic pressure difference (p <0.0001) and gender (p = 0.02) in severe stenosis. LV hypertrophy was present in 15 of 24 patients (63%) with mild AS, in 21 of 27 (78%) with moderate AS, and 32 of 40 (80%) with severe AS.
Conclusion: LV hypertrophy is common, even in mild AS, when it is independently related only to the systemic blood pressure. This suggests that antihypertensive agents should be considered early in the natural history of AS.